Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes from stem cells help improve nerve repair in rats.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Dermagraft and Dermalogen had a lot of granulation, while Alloderm, Integra, and ADM had good blood vessel growth for skin healing.

The demineralized bone matrix scaffold is better for cell attachment than the mineralized bone allograft.

High-quality data on skin cancer is crucial for understanding its trends and allocating healthcare resources effectively.

Social housing is a system for those with limited financial resources, needing subsidies and an allocation system, with Germany fitting this criteria.

Scalp flaps in hair restoration surgery provide immediate results, prevent temporal hair loss, offer great density, and allow for large hair re-allocation, making them a popular choice, especially in Asian countries.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

MicroRNAs could improve skin tissue engineering by regulating cells and changing the skin's bioactive environment.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Stem cells could potentially rebuild missing structures in wounds, improving facial skin replacement techniques.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

New scaffold materials help heal severe skin wounds and improve skin regeneration.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.